Dr. Caplan to Testify at DEA Rescheduling Hearings
We are thrilled to share that Dr. Benjamin Caplan, a leading voice in medical cannabis and Chief Medical Officer of The Commonwealth Project, has been invited to testify at the DEA’s upcoming rescheduling hearings. These hearings, now scheduled for early 2025, represent a historic opportunity to reshape cannabis policy in the United States.
Dr. Caplan’s testimony will focus on the critical role of cannabis in modern medicine, particularly for seniors and other vulnerable populations seeking safe and effective alternatives for managing pain, improving sleep, and enhancing quality of life. As a physician who has provided care and oversight to over 300,000 medical cannabis patients, Dr. Caplan brings a wealth of clinical experience and a deep understanding of the therapeutic benefits of cannabis.
The DEA’s rescheduling process could mark a turning point in cannabis policy, transitioning it from a Schedule I substance (considered to have no medical use) to Schedule III, where its medical potential would be officially recognized. Such a change would not only acknowledge the growing body of scientific evidence supporting cannabis’s therapeutic value but also expand access by easing some of the federal restrictions currently in place.
In preparation for this critical moment, Dr. Caplan ensured that both houses of Congress received copies of The Doctor-Approved Cannabis Handbook, his authoritative guide on the medical use of cannabis. By equipping policymakers with evidence-based knowledge, Dr. Caplan continues to advocate for informed and compassionate decision-making at the highest levels of government.
“This is more than a policy discussion,” Dr. Caplan stated. “It’s about recognizing the millions of patients whose lives have been transformed by cannabis and ensuring that no one is left behind in their journey to wellness.”
The hearings represent a critical moment in the fight for meaningful change, and Dr. Caplan is honored to lend his voice to this effort. He will join other stakeholders, including medical experts, patient advocates, and industry leaders, in presenting compelling evidence to the DEA in support of rescheduling cannabis.
Stay tuned for updates as we approach this pivotal event. Together, we are shaping the future of cannabis reform and working toward a healthcare system that embraces the full potential of cannabis as medicine.
For more information, visit CEDClinic.com.
Proud to announce that The Commonwealth Project is among the accepted testifiers for the DEA’s rescheduling hearings! Together, we’re driving the conversation forward for cannabis reform and senior care. 🌿 #CannabisReform #DEAhearings
